In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...
A recent study points to a potential link between GLP-1 drugs and its ability to reduce risk of epilepsy in people with type 2 diabetes. GLP-1 drugs (semaglutide) are those which mimic the function of ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback